Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2005
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005US20050228016 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005DE102004005186B3 Verfahren zur Herstellung von gereinigtem Ciprofloxacin A method for preparing purified ciprofloxacin
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2562114A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005CA2561560A1 Hydrazide-containing cftr inhibitor compounds and uses thereof
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/12/2005EP1584619A1 Derivatives of quinoline as inhibitors for MEK
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583532A1 Quinoline derivatives as glucokinase ligands
10/12/2005CN1681791A 8－羟基喹啉衍生物 8-hydroxyquinoline derivative
10/12/2005CN1681790A Method for producing a 3, 5-dihydroxy-6-heptenoate
10/12/2005CN1681789A 1-pyridin-4-yl-urea derivatives
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680328A Preparation of Alipioxazole
10/12/2005CN1680292A Compounds useful as intermediates of 4-aminoquinoline deravative
10/12/2005CN1222512C Process for the preparation of quinolylpropenal
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/06/2005WO2005092861A1 Quinolinone derivatives pharmaceutical compositions containing them and their use
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005075427A3 Montelukast sodium polymorphs
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222397 such as 4-methyl-6-chloro-7-aminoquinolone; simple to perform, high chemical and isomeric purity product in a high yield; intermediates to azo pigments
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222254 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222203 Nitrogen heterocycle biaryls for osteoporosis and other diseases
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222199 Process for the preparation of a hydrate of an antranilic acid derivative
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050221498 Quantitative method of determining beryllium or a compound thereof in a sample
10/06/2005DE10361794B3 Optisch aktive heteroaromatische ß-Hydroxy-Ester und Verfahren zu deren Herstellung sowie deren Verwendung als Zwischenprodukte bei der Epothilon-Totalsynthese Optically active heteroaromatic beta-hydroxy ester, and processes for their preparation and their use as intermediates in the total synthesis of epothilone-
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/05/2005EP1581500A2 Antibiotics containing borinic acid complexes and methods of use
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1676517A Aripiprazole crystal form
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005CA2146763C Quinolone and acridinone derivatives for the treatment of urinary incontinence
09/2005
09/29/2005WO2005090336A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090309A1 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
09/29/2005WO2005090308A1 Process for the synthesis of a cxcr4 antagonist
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090283A1 Methods of amination
09/29/2005WO2005090282A1 Androgen receptor modulator compounds and methods
09/29/2005WO2005089760A1 8-hydroxy-5-[(-hydroxy-2-[[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl] -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005WO2005054183A3 Quinolinone based protein kinase inhibitors
09/29/2005WO2005025507A3 Dihydropyridine compounds for treating or preventing metabolic disorders
09/29/2005US20050215825 Hydroaminomethylation of an olefin, a primary or secondary amine with a catalyst of a neutral rhodium-monodentate phosphite ligand complex prepared by contacting a neutral rhodium procatalyst with a monodentate phosphite ligand; chemical intermediate for ibutilide, terfenadine, and fexofenadine
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215791 Process for preparing aripiprazole
09/29/2005US20050215675 Organic pigment dispersant is sulfonated (8-o-carboxybenzoylamino)-2-(1,3-indanedion-2-yl)quinoline or sulfonated (8-o-carboxybenzoylamino)-2-(o-carboxybenzoylmethyl)quinoline or ammonium or metal salt; pigment carrier may be a copolymer of an alkylene oxide mono(meth)acrylic acid monoalkylphenol adduct
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215586 Such as N-ethyl-N-phenyl-1,2-dihydro-5-ethyl-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide by reacting a quinoline-3-carboxylic acid ester with an aniline derivative in a solvent of (cyclo)alkanes of given boiling point range; use of said solvent improves the yield and impurity profile
09/29/2005US20050215585 Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
09/29/2005CA2560650A1 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
09/29/2005CA2558389A1 Process for the synthesis of a cxcr4 antagonist
09/29/2005CA2558023A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578727A2 Tetrahydroquinoline derivatives and their use as fsh receptor modulators
09/28/2005EP1578726A2 Tetrahydroquinoline derivatives
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578423A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1674902A Novel crystalline forms of gatifloxacin
09/28/2005CN1673782A Colored composition for color filter and color filter
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949569 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/22/2005WO2005087759A1 Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc)
09/22/2005WO2005087742A1 Metabolic kinase modulators and methods of use as pesticides
09/22/2005WO2005087741A1 PHOTOCHARGE SEPARATION USING SUPRAMOLECULAR COMPLEX OF π-ELECTRON TYPE EXTENDED VIOLOGEN DERIVATIVE AND PORPHYRIN
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087227A1 Arylalkylamino-substituted quinazoline analogues
09/22/2005WO2005086844A2 Magnetism to control friction checks for rods
09/22/2005US20050209277 Such as N'-(1H-benzimidazol-2-ylmethyl)-N'-5,6,7,8-tetrahydroquinolin-8-yl-1,4-butanediamine; making chemokine receptor (CXCR4) antagonists useful as HIV antivirals; reacting a 5,6,7,8-tetrahydroquinolinylamine with an alkyl aldehyde bearing a phthalimide or a di-tert-butoxycarbonyl protecting group
09/22/2005US20050209276 Etherification, dehalogenation; filtration, crystallization; bactericides
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 277